In the aftermath of October 7th, we grapple with the challenge of addressing trauma and mental health needs and cannabis has emerged as a topic of heated discussion. Advocates point to its potential benefits, while critics warn against over-reliance and misuse.
In this post, I’ll explore the nuanced role cannabis can play in treating psychiatric disorders, based on insights shared by Prof. Eyal Fruchter, a leading psychiatrist specializing in PTSD and trauma.
The Promise and the Peril
Prof. Fruchter underscores that there is no medication that cures PTSD. “What resolves PTSD are therapies rooted in cognitive and behavioral processes,” he explains. While medications, particularly SSRIs like Zoloft and Cipralex, are FDA-approved for managing PTSD symptoms, they don’t address the core trauma.
This is where cannabis enters the conversation. For individuals struggling with sleep disturbances or intrusive flashbacks, cannabis may offer relief. However, as Prof. Fruchter notes, “Cannabis helps alleviate symptoms, but it’s not a cure. It’s like paracetamol—it reduces the fever but doesn’t treat the infection.”
“Cannabis helps alleviate symptoms, but it’s not a cure. It’s like paracetamol—it reduces the fever but doesn’t treat the infection.”
The Science—Or Lack Thereof
Despite anecdotal evidence of cannabis’ effectiveness for specific PTSD symptoms, robust clinical trials are still lacking. Unlike traditional psychiatric medications, which have undergone rigorous randomized controlled trials, cannabis remains in a gray zone.
“We don’t fully understand the mechanisms of cannabis,” says Prof. Fruchter. “When I prescribe a medication, I know exactly what’s in it. With cannabis, factors like sunlight and water levels can change the composition of the plant. It’s unpredictable.” This variability poses a significant challenge for clinicians seeking to offer consistent, reliable treatment.
From the 1960s to Today—A Different Beast
The cannabis of today is not the same as what was consumed in the 1960s and 70s. Back then, the THC concentration in cannabis rarely exceeded 5%. Today, it’s often 30-50% or higher, creating a much more potent product with increased risks.
“Modern cannabis is not the harmless substance many imagine,” warns Prof. Fruchter. “High-THC cannabis can lead to addiction, depression, and reduced motivation. We’ve seen cases of psychosis and significant cognitive decline. It’s not the benign drug it once was.”
The Problem of Over-Reliance
In Israel, cannabis usage among trauma patients has reached startling levels. The average global consumption is about 27.7 grams per month, but in Israel, the average among users is 47 grams—nearly double.
Prof. Fruchter points out that cannabis is often treated as a panacea, but without structured therapeutic interventions like Cognitive Behavioral Therapy (CBT), its benefits are temporary. “Without pairing cannabis with therapy, you’re not solving the problem; you’re silencing it. And that is true for all drugs, not just Cannabis.” he emphasizes. This short-term relief can lead to long-term issues, as underlying traumas remain unaddressed.
Addiction vs. Dependence
One of the most significant concerns with cannabis is its addictive potential. While traditional psychiatric medications like SSRIs are not habit-forming, cannabis can lead to dependence. Prof. Fruchter elaborates, “Unlike SSRIs, which don’t require increasing dosages over time, cannabis often does. Patients build tolerance, and higher doses become necessary, exacerbating dependency.”
A Balanced Approach
The solution isn’t to demonize cannabis or glorify it as a miracle cure. Instead, a balanced, evidence-based approach is needed.
“Cannabis can be a valuable tool in a larger treatment plan,” Prof. Fruchter explains. “For patients who struggle with severe sleep issues or flashbacks, it can provide immediate relief. But this relief must be paired with therapies like CBT to address the root causes of trauma.”
Building a Framework for Responsible Use
To move forward, Israel must invest in public health education and robust clinical research. This means:
Conducting Large-Scale Studies: Randomized controlled trials to understand who benefits most from cannabis and under what conditions.
Integrating Therapies: Ensuring that cannabis is used alongside evidence-based therapies, not as a standalone treatment.
Educating Practitioners: Training medical professionals to prescribe cannabis judiciously and monitor its effects.
Raising Public Awareness: Launching campaigns to dispel myths and set realistic expectations about cannabis’ role in mental health treatment.
A Call to Action
As Israel confronts a national trauma crisis, the stakes couldn’t be higher. Cannabis has a role to play, but it’s not a silver bullet. Prof. Fruchter’s insights remind us that while cannabis may provide symptomatic relief, true healing comes from addressing the underlying trauma.
“We need to think strategically,” Prof. Fruchter urges. “If we’re not careful, we’ll create a generation dependent on high-THC cannabis, with all the societal and health consequences that come with it. But with responsible use and proper integration, cannabis can be part of a larger solution to Israel’s mental health crisis.”
The journey toward healing is complex, but with thoughtful approaches, we can ensure that every tool—including cannabis—is used wisely to support those in need.
Comments